- +113.6% price growth over the last year
- High gross margin of 93.4%
- Strong operating margin of 41.6%
Rigel Pharmaceuticals stock price ended at $41.18 on Wednesday, after gaining 0.0243%
(Updated on Jul 15, 2026)
The Rigel Pharmaceuticals stock price gained 0.0243% on the last trading day (Wednesday, 15th Jul 2026), rising from $41.17 to $41.18. During the last trading day the stock fluctuated 2.96% from a day low at $40.39 to a day high of $41.59. The price has risen in 6 of the last 10 days and is up by 5.27% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 thousand more shares were traded than the day before. In total, 222 thousand shares were bought and sold for approximately $9.12 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 39.29% during the next 3 months and, with a 90% probability hold a price between $49.08 and $62.10 at the end of this 3-month period.
RIGL Signals & Forecast
The Rigel Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $42.21. On a fall, the stock will find some support from the long-term average at approximately $35.22. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -5.90%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Rigel Pharmaceuticals stock
On the downside, the stock finds support just below today's level from accumulated volume at $38.69 and $32.91. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rigel Pharmaceuticals finds support just below today's level at $38.69. If this is broken, then the next support from accumulated volume will be at $32.91 and $32.13.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.20 between high and low, or 2.96%. For the last week, the stock has had daily average volatility of 4.07%.
Our recommended stop-loss: $38.92 (-5.49%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 4 days ago.)
Trading Expectations (RIGL) For The Upcoming Trading Day Of Thursday 16th
For the upcoming trading day on Thursday, 16th we expect Rigel Pharmaceuticals to open at $41.05, and during the day (based on 14 day Average True Range), to move between $40.33 and $42.03, which gives a possible trading interval of +/-$1.71 (+/-4.23%) up or down from last closing price. If Rigel Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $41.30 (0.29%) than the support at $38.69 (6.05%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Rigel Pharmaceuticals stock A Buy?
Rigel Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.182
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 16, 2026 - $41.05 ( 0.312%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
RIGL Performance
Trading levels for RIGL
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 42.25 | 2.59% |
| R2 | 41.79 | 1.48% |
| R1 | 41.51 | 0.797% |
| Price | 41.18 | |
| S1 | 40.60 | -1.42% |
| S2 | 40.31 | -2.11% |
| S3 | 39.86 | -3.21% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 42.56 | 3.35% |
| R2 | 42.55 | 3.33% |
| R1 | 41.30 | 0.291% |
| Price | 41.18 | |
| S1 | 38.69 | -6.05% |
| S2 | 32.91 | -20.08% |
| S3 | 32.13 | -21.98% |
FAQ
Click here for our free guide on how to buy Rigel Pharmaceuticals Stock.
Buy RIGL